MicrobeWorld App

appsquarebannerad200x200

ASM Fellowships

Fellowship

Microbes After Hours

Watter-Supply-200x200-Banner

Click for more "Microbes After Hours" videos

Join MicrobeWorld

Subscribe via Email

subscribe

Featured Image

Featured Video

Ebola Virus explained

Supporters

ASM House 200X200

Drug-resistant TB at record levels worldwide, the WHO says

An estimated 440,000 people had multi-drug resistant tuberculosis in 2008 and a third of them died as the new variant of the TB mycobacterium continues to spread, the World Health Organization said Thursday. Nearly half of the cases were in China and India, which have been hit hardest by the outbreak. But in some areas of the world, especially three provinces in Russia, more than one in every four cases of tuberculosis are the result of the hard-to-treat strain, according to the report.

Worldwide, there were an estimated 9.4 million cases of TB and 1.8 million deaths, so the drug-resistant forms remain a relatively small problem. But experts fear that they will continue to spread, displacing the drug-susceptible strains and greatly complicating treatment and increasing its cost.

Multidrug-resistant TB (MDR-TB) is caused by bacteria that are resistant to at least isoniazid and rifampicin, the anti-TB drugs most commonly used. It may be caused by infection with the resistant bacterium or the resistance may appear during treatment. It is most commonly caused by failure to complete the normal six-month course of treatment or the use of substandard or counterfeit drugs. A course of treatment for MDR-TB can take as long as two years and cost as much as $500, compared with six months and $20 for treatment with standard drugs. About 60% of those who are diagnosed with the variant are cured, according to the WHO.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use